Bioporto

Description

Bioporto provides clinicians with NGAL biomarker tools for acute kidney injury risk assessment and diagnosis, and supplies NGAL ELISA kits for human Phase 1 trials and preclinical animal studies.

Bioporto is located in the Copenhagen ecosystem.

Related

• Trackpaw scientificTrackpaw scientific digitizes preclinical animal studies by continuously tracking mice health parameters (weight, activity, respiratory) to…
• BactolifeBactolife A/S develops binding-protein ingredients for functional foods and animal feed as affordable biotech solutions, supporting human…
• CFM PharmaCFM Pharma is a Dutch clinical-stage biotech developing VANADIS®, a platform for tissue protection and repair in acute injury, with…
• NovonesisNovonesis brings sales and distribution together with research and innovation for animal feed enzymes, microbes, and probiotics, supporting…
• numares HEALTHnumares HEALTH develops biomarker tests that use nuclear magnetic resonance spectroscopy and machine learning to quantify serum metabolites…
• Rab DiagnosticsRab Diagnostics develops biomarker tools, assays and the RabCANCER platform to predict antibody–drug conjugate response for pharma…
• ScientaLabScientaLab develops a foundation model that predicts human immune response in immunology and inflammation, using multi-disease,…
• BiograilBiograil develops proprietary BIONDD® technology for oral delivery of biologics, using it in preclinical pharmaceutical work to turn…
• IBA LifesciencesIBA Lifesciences develops research tools based on Strep-tag® technology for protein and cell isolation, providing purification and analysis…